Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers reveal how pneumonia-causing bacteria obtain essential nutrient from our bodies

Australian researchers have revealed how the bacterium Streptococcus pneumoniae (pneumococcus) obtains the essential nutrient, manganese, from our bodies, which could lead to better therapies to target what is a life-threatening, antibiotic-resistant pathogen.

6 Aug 2021

Study: IgG antibodies against SARS-CoV-2 remain stable, or even increase, seven months after infection

The levels of IgG antibodies against SARS-CoV-2 Spike protein remain stable, or even increase, seven months after infection, according to a follow-up study in a cohort of healthcare workers coordinated by the Barcelona Institute for Global Health, an institution supported by "la Caixa" Foundation, in collaboration with the Hospital Clinic of Barcelona.

6 Aug 2021

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

A new study from Japan, released as a medRxiv* preprint, describes the adverse effects associated with the vaccine. Such data is crucial in delineating the safety and efficacy of this intervention in various age groups.

6 Aug 2021

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

Collaborative international clinical trials testing full dose anticoagulation with heparin (a blood thinner) in both moderately ill and critically ill patients has found the treatment improves outcomes and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients.

6 Aug 2021

New method for producing pseudotyped virus particles bearing spike protein of SARS-CoV-2

A new study discusses the development of an improved protocol based on cell lines that can consistently express S proteins.

5 Aug 2021

Zoonotic disease surveillance must be integrated into health security intelligence systems, experts say

The surveillance of zoonotic diseases must be integrated into health security intelligence systems, if future pandemics are to be handled effectively, according to global health practitioners writing in the Journal of the Royal Society of Medicine.

5 Aug 2021

Immune system signaling molecule promotes the production of energy-burning 'beige fat'

An immune signal promotes the production of energy-burning "beige fat," according to a new study publishing August 5th in the open-access journal PLOS Biology by Zhonghan Yang of Sun Yat-Sen University, Guangzhou, China, and colleagues.

5 Aug 2021

Nine things parents should know about the Delta variant to keep children safe as schools reopen

Despite the rise in Delta variant cases, increased hospitalizations and reinstated mask mandates, many schools are set to reopen as early as next week.

5 Aug 2021

Vaccinia-based COVID-19 vaccines confer immunity in hamster model

In a paper recently uploaded to the preprint server bioRxiv* by Kulkarni et al. (August 3, 2021), the potential of vaccinia virus-based vaccines expressing the full-length SARS-CoV-2 spike protein is examined in mice and Syrian hamsters. The findings report that the vaccine generates high titers of neutralizing antibodies with good activity towards SARS-CoV-2 variants of concern.

5 Aug 2021

How does the mRNA/lipid nanoparticle platform promote protective adaptive immunity against SARS-CoV-2?

Modified mRNA combined with lipid nanoparticles may be beneficial in boosting adaptive immunity against SARS-CoV-2. Research led by Botond Z. Igyártó from Thomas Jefferson University’s Department of Microbiology and Immunology in Pennsylvania recently found that the lipid nanoparticles induce protective adaptive immune responses with antibody titers against lethal doses of the virus.

5 Aug 2021

The role of natural killer cells in the fight against coronavirus infection

This study proposes a mathematical framework to analyze the effect of the viruses on type I interferon (IFN-I) signaling, which is part of the innate immune response. IFN-I brings about natural killer cell activation, which in turn causes the activation of macrophages.

4 Aug 2021

Initiating therapeutic anticoagulation benefits moderately ill COVID-19 patients, but not critically ill patients

A large clinical trial conducted worldwide shows that treating moderately ill hospitalized COVID-19 patients with a full-dose blood thinner reduced their need for organ support, such as mechanical ventilation, and improved their chances of leaving the hospital.

4 Aug 2021

Simple text messages can increase COVID-19 vaccine uptake

New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.

4 Aug 2021

Flu vaccine may provide vital protection against COVID-19, study shows

In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.

4 Aug 2021

Data shows worrying rise in pregnant women admitted to hospital with symptomatic COVID-19

The Chief Midwifery Officer for England will urge expectant mums to have their COVID-19 vaccination as soon as possible.

4 Aug 2021

One billion doses of Oxford-AstraZeneca COVID-19 vaccine released

The University of Oxford's and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca's joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

4 Aug 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers reveal how pneumonia-causing bacteria obtain essential nutrient from our bodies

Study: IgG antibodies against SARS-CoV-2 remain stable, or even increase, seven months after infection

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

New method for producing pseudotyped virus particles bearing spike protein of SARS-CoV-2

Zoonotic disease surveillance must be integrated into health security intelligence systems, experts say

Immune system signaling molecule promotes the production of energy-burning 'beige fat'

Nine things parents should know about the Delta variant to keep children safe as schools reopen

Vaccinia-based COVID-19 vaccines confer immunity in hamster model

How does the mRNA/lipid nanoparticle platform promote protective adaptive immunity against SARS-CoV-2?

The role of natural killer cells in the fight against coronavirus infection

Initiating therapeutic anticoagulation benefits moderately ill COVID-19 patients, but not critically ill patients

Simple text messages can increase COVID-19 vaccine uptake

Flu vaccine may provide vital protection against COVID-19, study shows

Data shows worrying rise in pregnant women admitted to hospital with symptomatic COVID-19

One billion doses of Oxford-AstraZeneca COVID-19 vaccine released

‘Wisdom and fear’ lead 90% of U.S. seniors to covid vaccines

Parts of Lake Tahoe close after chipmunks test positive for plague

Next-Generation Sequencing and the Diagnosis of Disease

Nasal version of AstraZeneca SARS-CoV-2 vaccine prevents infection in animal models

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in